Skip to content

Application of imprinted gene diagnosis in Thyroid carcinoma

Application of imprinted gene diagnosis in Thyroid carcinoma

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900025265
Enrollment
Unknown
Registered
2019-08-18
Start date
2019-09-01
Completion date
Unknown
Last updated
2019-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroid carcinoma

Interventions

Sponsors

Shanghai Tenth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Aged 14 to 85 years; 2. After general ultrasonography, patients with suspected thyroid lesions with malignant risk will undergo FNA examination; 3. The patients are willing to sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients who do not understand the research process, or who are unable/unwilling to answer questionnaires, provide medical records, examination reports and other relevant information; 2. Patients who do not receive surgical treatment and do not complete follow-up.

Design outcomes

Primary

MeasureTime frame
imprinted gene;SEN, SPE, ACC, AUC of ROC;

Countries

China

Contacts

Public ContactHui-xiong Xu

Shanghai Tenth People's Hospital

xuhuixiong@126.com+86 18917683519

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026